Loading...
•
Jun 30, 2022
Glaukos Q2 2022 Earnings Report
Glaukos reported a decrease in net sales but an increase in gross margin and non-GAAP gross margin compared to the same quarter last year. The company is focused on launching new products and advancing its pipeline of novel platform technologies.
Key Takeaways
Glaukos Corporation announced its second quarter 2022 financial results, with net sales of $72.7 million. The company's gross margin was approximately 75%, and non-GAAP gross margin was approximately 83%. Glaukos raised its 2022 net sales guidance to $275 million to $280 million.
Net sales reached $72.7 million.
Glaucoma net sales were $56.1 million.
Corneal Health net sales totaled $16.6 million.
Gross margin was approximately 75%, while non-GAAP gross margin was approximately 83%.
Glaukos
Glaukos
Glaukos Revenue by Segment
Revenue by Segment
Glaucoma Revenue
CapyFin.com Forward Guidance
The company expects 2022 net sales to be in the range of $275 million to $280 million.